Rizalinda Sjahril

Rizalinda Sjahril

Auto-generated profile, based on publicly available information

Rizalinda Sjahril

Hasanuddin University Faculty of Medicine, Department of Microbiology, Makassar, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
MCMaisuri Tadjuddin Chalid
Maisuri Tadjuddin Chalid
TUTuryadi
Turyadi
SISusan I. Ie
Susan I. Ie
RSRizalinda Sjahril
Rizalinda Sjahril
RWRidha Wahyuni
Ridha Wahyuni
DMDavid Handojo Muljono
David Handojo Muljono
Maternal hepatitis B e Antigen (HBeAg) positivity poses a risk for hepatitis B virus (HBV) mother‐to‐child transmission (MTCT). In resource‐constrained settings, HBeAg testing is recommended as an alternative to HBV DNA testing to establish antiviral prophylaxis eligibility. Nevertheless, the high prevalence of HBeAg‐negative chronic hepatitis B (e‐CHB) in many countries should not be overlooked. We studied HBV characteristics and explored the potential MTCT risk among HBeAg‐negative/HBsAg‐positive expectant mothers in an area prevalent of e‐CHB. Among 1348 pregnant mothers screened for HBV infection, 81 (6.0%) were HBsAg‐positive. These women were examined for HBeAg, HBV DNA, and cord blood HBV DNA. Sixteen (19.8%) of the HBsAg‐positive mothers were HBeAg‐positive, whereas 65 (80.2%) were HBeAg‐negative, including eight inactive carriers (HBsAg <100 IU/ml, HBV DNA ≤ 2000 IU/ml, and ALT < 40 IU/L). Of the remaining 57 HBeAg‐negative mothers, ten revealed HBV Basal Core Promoter or Precore mutations, with three having high viremia (HBV DNA > 200 000 IU/mL), which is associated with a high MTCT risk and therefore qualifies them for antiviral prophylaxis. This pilot study provides a cautionary note to the interpretation of negative HBeAg test results when determining eligibility for MTCT antiviral prophylaxis in situations with limited resources and in regions where e‐CHB is prevalent.

1 December 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
OWO. Waworuntu
O. Waworuntu
RSR. Sjahril
R. Sjahril
YRY.D. Rasita
Y.D. Rasita
MMM. Munawir
M. Munawir

13 July 2022 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
DUDian Utami
Dian Utami
MCMaisuri Tadjuddin Chalid
Maisuri Tadjuddin Chalid
RMRina Masadah
Rina Masadah
RSRizalinda Sjahril
Rizalinda Sjahril
AFAndi Dwi Bahagia Febriani
Andi Dwi Bahagia Febriani
Introduction. The placenta is a specialized organ that only performs during pregnancy and serves as an immunological barrier in preventing pathogens to reach the fetus. It has been known that toll-like receptors (TLRs) on the placenta respond to antigens, such as zymosan, lipopolysaccharide, and other viral infections. This study analyzes the distribution of TLR2 protein and hepatitis B DNA virus (HBV DNA) virus identification to gain an understanding of hepatitis B viral transmission from the mother to child. Methods. We performed enzyme-linked immunoadsorbent assay of HBeAg, HBsAg titer, Anti-HBs, and Anti-HBc to 59 HBsAg-positive pregnant women and identified HBV DNA using nested PCR in their cord blood during delivery for evidence of exposure to HBV DNA. The expression of TLR2 protein in the placenta was performed using immunohistochemistry analysis. Results. Intrauterine exposure to the hepatitis B virus occurred in 69.5 of all pregnant women who were HbsAg positive. TLR2 expression was predominantly identified in syncytiotrophoblast and cytotrophoblast cells with the highest score in mothers aged 2035 years (75), multigravida (58.3), and mothers with term pregnancies (70.8). Statistical analysis results showed that placental TLR2 expression did not indicate any association with hepatitis B virus DNA identified in cord blood with a p value of 0.730 and an OR of 0.650 (95 CI 0.1732.440). Conclusion. TLR2 expression is not associated with intrauterine exposure of hepatitis B virus.

1 January 2021 in Journal of Advanced Veterinary and Animal Research
Verified
Journal Article
Open access
DMDewi Mutisari
Dewi Mutisari
MMMuflihanah Muflihanah
Muflihanah Muflihanah
HWHendra Wibawa
Hendra Wibawa
FHFerra Hendrawati
Ferra Hendrawati
HPHamdu Putra
Hamdu Putra
MMMuhammad Nasrum Massi
Muhammad Nasrum Massi
A phylogenetic study was carried out on the avian influenza virus (AIV) isolated from a disease outbreak in Sidenreng Rappang Regency, South Sulawesi, Indonesia, in 2018. Oropharyngeal swabs and organ samples were obtained from ducks that showed clinical symptoms: torticollis, fascial edema, neurological disorders, the corneas appear cloudy, and death occurs less than 1 day after symptoms appear. In this study, isolate A/duck/Sidenreng Rappang/07180110-11/2018 from duck was sequenced and characterized. It was found that each gene segment of the virus has the highest nucleotide homology to the Indonesian highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.2.1c. Multiple alignments of the sample Hemagglutinin (HA) gene with the avian influenza references virus showed that the pattern of amino acid arrangement in the cleavage site PQRERRRK-RGLF is the characteristic of the HPAI virus. In addition, the HA gene contained Q222 (glutamine) and G224 (glycine), signifying a high affinity to avian receptor binding specificity (SA α2,3 Gal). Furthermore, there was no genetic reassortment of this virus based on the phylogenetic analysis of HA, NA, PB1, PB2, PA, NP, M, and NS genes. The HPAI H5N1 clade 2.3.2.1c virus was identified in duck farms in South Sulawesi, Indonesia.

30 June 2026 in Medeniyet Medical Journal
Verified
Journal Article
Open access
PDF file
MPMarojahan Pandiangan
Marojahan Pandiangan
MGMasyita Gaffar
Masyita Gaffar
RDRiskiana Djamin
Riskiana Djamin
AZandi alfian Zainuddin
andi alfian Zainuddin
RSRizalinda Sjahril
Rizalinda Sjahril
MAMuhammad Amsyar Akil
Muhammad Amsyar Akil
Exploring the Link Between Bacterial Biofilm and Disease Severity in Cholesteatoma-Associated CSOM - Medeniyet Medical Journal

23 February 2024 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
MCMaisuri Tadjuddin Chalid
Maisuri Tadjuddin Chalid
RJRaden Tina Dewi Judistiani
Raden Tina Dewi Judistiani
RSRizalinda Syahril
Rizalinda Syahril
RMRina Masadah
Rina Masadah
DFDwi Bahagia Febriani
Dwi Bahagia Febriani
MMMuhammad Nasrum Massi
Muhammad Nasrum Massi
BACKGROUND: The risk factors for intrauterine transmission of hepatitis B virus (HBV) in hepatitis B surface antigen (HBsAg)-positive pregnant women are poorly understood. Numerous factors are considered to be involved, including placental barrier, obstetric environment, high viral load, and positivity of hepatitis B e antigen (HBeAg). This study was conducted to investigate the role of placenta barrier, clinical, and viral factors in intrauterine transmission of HBV.METHODS: A cross-sectional study was conducted involving 1,353 pregnant women who underwent HBsAg screening. Eighty-four (6.2%) women were detected as HBsAg positive and were examined for HBsAg level, anti-HBs, anti-HBc, HBeAg/hepatitis B e antibody (anti-HBe) status, and HBV DNA presence in cord blood. Quantitative HBV DNA was analyzed using real-time polymerase chain reaction (PCR).RESULTS: Eighty-four of 1,353 subjects were HBsAg-positive. HBV DNA was positive in 28/84 (33.7%) maternal sera, 19/79 (24.05%) placental specimens, and 9/83 (10.84%) in cord blood. There were significant associations between HBV DNA in maternal serum (p=0.000) and placental tissue (p=0.000) with HBV DNA in the cord blood. No clinical factors were associated with HBV DNA transmission in cord blood. Sixty percent of viral load >5.3 log10 copies/mL were found in the cord blood, of which 43.8% HBeAg positive and 3.1% HBeAg negative.CONCLUSION: Reduced transmission via compartments established the placenta’s barrier function in mother-to-child transmission. A high maternal viral load and positive HBeAg were risk factors for intrauterine transmission, while negative HBeAg still has the possibility of transmission.KEYWORDS: mother-to-child transmission, hepatitis B virus, intrauterine